Stratos Investment Management LLC Has $281,000 Stake in HCA Healthcare, Inc. (NYSE:HCA)

Stratos Investment Management LLC decreased its stake in HCA Healthcare, Inc. (NYSE:HCA) by 5.5% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 936 shares of the company’s stock after selling 55 shares during the period. Stratos Investment Management LLC’s holdings in HCA Healthcare were worth $281,000 at the end of the most recent quarter.

Other hedge funds have also recently added to or reduced their stakes in the company. FMR LLC raised its position in shares of HCA Healthcare by 322.3% during the third quarter. FMR LLC now owns 3,141,769 shares of the company’s stock worth $1,276,909,000 after purchasing an additional 2,397,883 shares during the period. Meritage Group LP acquired a new stake in shares of HCA Healthcare during the third quarter worth about $150,548,000. Canoe Financial LP raised its position in shares of HCA Healthcare by 226,952.9% during the fourth quarter. Canoe Financial LP now owns 231,594 shares of the company’s stock worth $69,513,000 after purchasing an additional 231,492 shares during the period. Holocene Advisors LP raised its position in shares of HCA Healthcare by 210.6% during the third quarter. Holocene Advisors LP now owns 306,796 shares of the company’s stock worth $124,691,000 after purchasing an additional 208,015 shares during the period. Finally, Nordea Investment Management AB grew its holdings in shares of HCA Healthcare by 29.7% during the fourth quarter. Nordea Investment Management AB now owns 843,764 shares of the company’s stock worth $253,020,000 after buying an additional 193,075 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Activity

In other news, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction dated Thursday, November 14th. The stock was sold at an average price of $353.00, for a total value of $1,023,700.00. Following the completion of the sale, the insider now owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. This represents a 29.76 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the sale, the senior vice president now directly owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. The trade was a 6.89 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently issued reports on the company. Bank of America decreased their price objective on HCA Healthcare from $380.00 to $370.00 and set a “buy” rating for the company in a report on Monday, January 27th. KeyCorp decreased their price objective on HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a report on Tuesday, January 7th. Truist Financial decreased their price objective on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a report on Monday, January 6th. JPMorgan Chase & Co. restated a “neutral” rating and issued a $380.00 price target on shares of HCA Healthcare in a research note on Tuesday, December 17th. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $405.00 price target on shares of HCA Healthcare in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Stock Performance

NYSE:HCA opened at $336.93 on Thursday. The stock has a market cap of $85.34 billion, a P/E ratio of 15.34, a PEG ratio of 1.13 and a beta of 1.64. The stock has a 50 day simple moving average of $313.64 and a 200 day simple moving average of $353.69. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter in the previous year, the company posted $5.90 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 24.89 earnings per share for the current year.

HCA Healthcare Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, March 31st. Stockholders of record on Monday, March 17th will be paid a $0.72 dividend. This is a positive change from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. This represents a $2.88 annualized dividend and a dividend yield of 0.85%. HCA Healthcare’s dividend payout ratio (DPR) is presently 12.02%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.